Glasgow Alcoholic Hepatitis Score
Predicts 28-day mortality in alcoholic hepatitis. Score ≥9 identifies patients likely to benefit from corticosteroids.
Score interpretation
28-day survival ~87%. Lower risk of short-term mortality.
→ Supportive care; nutritional support; alcohol abstinence. No survival benefit from corticosteroids with GAHS < 9 (Forrest 2007).
28-day survival ~46%. High short-term mortality.
→ If the modified discriminant function is also ≥ 32, corticosteroids improve survival (Forrest 2007): prednisolone (adults: 40 mg/day × 28 days); reassess at 7 days with Lille score. Children: use a children's formulary.
Interpretation bands for the Glasgow AH Score. Apply clinical judgement and local guidance.
References
- Forrest EH, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54(8):1174–1179.
- Forrest EH, et al. The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut. 2007;56(12):1743–1746.
Related
Curated clinical cross-links plus same-class fallbacks.
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
- Entecavir · Antiviral — Hepatitis B (Nucleoside Analogue)
- Tenofovir (TDF/TAF) · Antiviral — Hepatitis B (Nucleotide Analogue)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
